Digidentity Advanced and Qualified eSignatures now available direct from Adobe
The Hague, Netherlands, 8 September 2021: Digidentity, a Solera company, Europe’s most innovative online identity…
The Hague, Netherlands, 8 September 2021: Digidentity, a Solera company, Europe’s most innovative online identity…
SANTA CLARA, Calif., 08 September, 2021 — prpl Foundation, a community-driven consortium, dedicated to the…
Firm moving to a digital environment with additional application integrations on the cards including records…
Important milestone reached in the development of antibody fragment-based therapeutics for geographic atrophy under collaboration…
Leuven, BE, Boston, MA, US – September 8 – 08.00 AM CET Oxurion NV (Euronext…
Press Release 8 September 2021 Immunicum and the University Medical Center Groningen Receive a Grant…
Geneva, Switzerland, September 8, 2021 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric…
Sanofi to acquire Kadmon to further strengthen growth of transplant business Adds Rezurock™ (belumosudil) an…
REGULATED INFORMATION The interim financial report is prepared in accordance with article 13 of the…
UNIONDALE, N.Y., Sept. 08, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical…
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Works against mutant strains including Delta No need for refrigeration during transport and storage No…
CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical…
TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
MALVERN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused…
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
COPENHAGEN, Denmark, Sept. 07, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
– TransCon IL-2 β/γ is an investigational long-acting prodrug designed to improve cancer immunotherapy through the…
PITTSBURGH, Sept. 07, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (“AzurRx” or the…